The Process and Timeline
The Process
Key Dates
HP 2020 Advisory Committee
Learn More
How does the process work?
An Advisory Committee is established.
The Advisory Committee holds hearings to listen to the concerns of experts and the public.
A draft of HP 2020 is created.
Additional comments are invited.
Release of the Final HP 2020
Read how men's health advocates helped change HP 2010.
Key dates:
2008 - Meetings of Secretary's Advisory Committee on National Health Promotion and Disease Prevention Objectives for 2020
Spring 2008 - Six regional meetings across the nation
2008 to 2009 - Public input and comment
Late 2008/Early 2009 - Release of Healthy People 2020 framework
January 2010 - Launch of Healthy People 2020 (goals, objectives, & action plans)
HP 2020 Advisory Committee
On February 1, 2008, HHS Secretary Leavitt announces members of the Secretary’s Advisory Committee On National Health Promotion and Disease Prevention Objectives for 2020
The press release read, in part:
HHS Secretary Mike Leavitt today announced members of the advisory committee that will make recommendations for developing and implementing national health promotion and disease prevention objectives for Healthy People 2020.
Since 1979, Healthy People has set and monitored national health objectives to meet a broad range of health needs, engage people across the nation to work together, guide individuals toward making informed health decisions, and measure the impact of prevention activity.
The program leverages scientific insights and lessons learned from the past decades, along with knowledge of current data, trends and innovations, to develop health promotion and disease prevention objectives for the coming decade. Healthy People 2020 will reflect assessments of major risks to health and wellness, changing public health priorities, and emerging technologies related to our nation’s health.
“We are facing a growing epidemic of obesity and related chronic illnesses. The people we’ve invited to serve on this advisory committee will bring the best of the nation’s expertise to bear on the problem,” Secretary Leavitt said. “I look forward to working with them to develop a vision, a goal, and a plan for improving our nation’s health by the year 2020.
The Secretary’s Advisory Committee on National Health Promotion and Disease Prevention Objectives for 2020 is holding its first meeting Jan. 31- Feb 1, 2008, in Washington, D.C. The committee will survey the history of the Healthy People initiative and begin deliberations on the vision, mission, overarching goals, framework, and focus areas for Healthy People 2020.
Who are the HP 2020 Advisory Committee members?
Members of the Secretary’s Advisory Committee on Health Promotion and Disease Prevention Objectives for 2020 are:
Chair
Jonathan Fielding, M.D., MPH, MA, MBA, director public health and health officer, Los Angeles County; professor, schools of Public Health and Medicine, University of California, Los Angeles
Vice-Chair
Shiriki Kumanyika, Ph.D., MPH, associate dean for health promotion and disease prevention, professor of epidemiology, Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia
Committee Members
W. Douglas Evans, Ph.D., vice president for public health and environment, RTI International, Washington, D.C.
Vincent Felitti, M.D., founding chairman, department of preventive medicine, Kaiser Permanente, San Diego; clinical professor of medicine, University of California, San Diego
Everold Hosein, Ph.D., communication advisor-consultant, World Health Organization Communicable Diseases Section, WHO Mediterranean Center for Vulnerability Reduction, WHO Geneva and Tunis; codirector and adjunct professor, Indiana University, Global Health Communication Research and Resources Center; coordinator, WHO/NYU Integrated Marketing Communication for Behavioural Impact Summer Institute; Carmel, Ind.
Lisa Iezzoni, M.D., MSc., professor of medicine, Harvard Medical School; associate director, Institute for Health Policy, Massachusetts General Hospital, Boston.
Abby King, Ph.D., professor, departments of health research and policy and medicine, Stanford Prevention Research Center, Stanford University School of Medicine; Stanford, Calif.
Ronald Manderscheid, Ph.D., director of mental health and substance use programs, Global Health Sector, SRA International; adjunct professor, Department of Mental Health, Bloomberg School of Public Health, Johns Hopkins University; Rockville, Md.
David O. Meltzer, M.D., Ph.D., associate professor, departments of Medicine and Economics, and School of Public Policy Studies, The University of Chicago.
Eva Moya, LMSW, tuberculosis division director, United States-Mexico Border Health Association; Advocacy Communication and Social Mobilization, Project Concern International; University of Texas at El Paso College of Health Sciences Interdisciplinary Health Sciences Ph.D.. Program Student; El Paso, Texas.
Patrick Remington, M.D., MPH, professor, University of Wisconsin School of Medicine and Public Health; public health director, University of Wisconsin Population Health Institute; Madison.
David Siegel, M.D., MPH, assistant director, Health Care Operations and Programs, General Motors Health Services, Detroit.
Adewale Troutman, M.D., MPH, director, Louisville Metro Department of Public Health and Wellness; associate professor, School of Public Health and Information Sciences, University of Louisville; Louisville, Ky.
Learn More about HP 2020
To learn more about HP2020, please go to www.HealthyPeople.gov .